Etienne Binant Chief Executive Officer - Biom’ Up<br />
<br />
Founded in 2005, Biom’Up, a specialist in collagen-based absorbable medical devices for biosurgery, is developing a new generation hemostatic product composed of patent-protected biopolymers.<br />
With broad expertise in biomaterials, Biom’Up is creating innovative and clinically proven products that are used in many surgical specialties such as cardiothoracic and general surgeries.<br />
Biom’Up is committed to the design, development, and delivery of novel, high-performing solutions that make life easier for surgeons and better for patients.<br />
In 2017 Biom’Up has launched its IPO on the Euronext regulated market in Paris and raise 38,1 M€